Compare · DFTX vs NAII
DFTX vs NAII
Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and Natural Alternatives International Inc. (NAII): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DFTX and NAII operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- DFTX is the larger of the two at $4.72B, about 732.7x NAII ($6.4M).
- DFTX has been more active in the news (9 items in the past 4 weeks vs 1 for NAII).
- DFTX has more recent analyst coverage (8 ratings vs 0 for NAII).
- Company
- Definium Therapeutics Inc.
- Natural Alternatives International Inc.
- Price
- $34.46-0.43%
- -
- Market cap
- $4.72B
- $6.4M
- 1M return
- +0.20%
- -
- 1Y return
- +183.50%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 9
- 1
- Recent ratings
- 8
- 0
Natural Alternatives International Inc.
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Latest DFTX
- SEC Form 10-Q filed by Definium Therapeutics Inc.
- Definium Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Definium Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights
- Definium Therapeutics Announces New Employee Inducement Grants
- SEC Form SCHEDULE 13G filed by Definium Therapeutics Inc.
- Definium Therapeutics Presents Topline Phase 3 Data for DT120 ODT in Generalized Anxiety Disorder and Major Depressive Disorder at 2026 NEI Fall Congress
- Definium Therapeutics to Participate at Upcoming Investor Conferences
- Definium Therapeutics to Report Third Quarter 2026 Financial Results on November 9, 2026
- Definium Therapeutics Announces New Employee Inducement Grants
- Definium Therapeutics Announces New Employee Inducement Grants
Latest NAII
- SEC Form DEF 14A filed by Natural Alternatives International Inc.
- Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results
- SEC Form 10-K filed by Natural Alternatives International Inc.
- SEC Form S-8 filed by Natural Alternatives International Inc.
- SEC Form 10-Q filed by Natural Alternatives International Inc.
- SEC Form NT 10-Q filed by Natural Alternatives International Inc.
- CarnoSyn® Brands Expands TriBsyn® Applications Across Beverage, Dairy, and Medical Nutrition
- Natural Alternatives International Inc. filed SEC Form 8-K: Leadership Update
- CarnoSyn® Brands Launches CarnoSyn® 4X, a Next-Generation Beta-Alanine for Sports Performance
- Natural Alternatives International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits